Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Biomx Inc PHGE

Alternate Symbol(s):  PHGE.U | PHGEW

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer... see more

Recent & Breaking News (NYSEAM:PHGE)

BiomX to Report Second Quarter 2020 Financial Results on Aug. 13, 2020

Business Wire August 6, 2020

BiomX Reports First Quarter 2020 Financial Results and Provides Business Update

Business Wire May 14, 2020

BiomX to Announce First Quarter 2020 Financial Results on May 14, 2020

Business Wire May 11, 2020

BiomX Announces Date of 2020 Annual Meeting of Stockholders

Business Wire April 7, 2020

BiomX Announces Positive Topline Data from Phase 1 Study for Lead Candidate BX001 for Acne-Prone Skin

Business Wire March 31, 2020

BiomX Reports Full Year 2019 Financial Results and Provides Business Update

Business Wire March 26, 2020

BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting

Business Wire March 20, 2020

BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference

Business Wire February 17, 2020

BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange

Business Wire February 3, 2020

Chardan Acts as M&A Advisor in Health Sciences Acquisitions Corporation Completed Merger with Immunovant

PR Newswire December 19, 2019

BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin

Business Wire December 2, 2019

BiomX Presents Preclinical Results of its Phage Therapy Program Targeting Primary Sclerosing Cholangitis

Business Wire November 12, 2019

BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director

Business Wire November 4, 2019

BiomX To Present at Plenary Session of the AASLD Liver Conference

Business Wire November 4, 2019

Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

PR Newswire October 28, 2019

Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.

PR Newswire October 23, 2019

ACT NOW: Monteverde & Associates PC Continues Legal Inquiry Regarding the Merger

ACCESSWIRE IA October 19, 2019

Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.

PR Newswire October 14, 2019

Lifshitz & Miller LLP Announces Investigation of Altria Group, Inc., Chardan Healthcare Acquisition Corporation, Premier, Inc., Restoration Robotics, Inc., Vivint Solar, Inc., Waitr Holdings Inc., Xilinx, Inc., and Zscaler, Inc.

PR Newswire October 10, 2019

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigations of Mergers

GlobeNewswire October 3, 2019